Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147291807> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W3147291807 abstract "Objective Chronic graft versus host disease (cGVHD) is the most common late complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and it represents the major cause of mortality in long-term survivors. Over the past decade, although conventional therapy has achieved complete responses in approximately 50% of patients, the prophylaxis and treatment of cGVHD are still not satisfactory. In the late years, utilization of new immunosuppressant such as tacrolimus (FK506), mycophenolate mofetil (MMF) on cGVHD improved the curative effects. This study tried to analyze the results of combination of methylprednisolone (MP), MMF and FK506 or cyclosporine A (CSA) as immunosuppressive therapies for cGVHD and to explore the effective regimen for children. Methods Forty-five patients received allo-HSCT. Among them 32 received UCBT and 13 received PBSCT. The conditional regimen mainly consisted of busalphan, cyclophosphamide, antihuman thymocyte globulin, fludarabin, melphalan, thiotepa and total lymph node irradiation. Prophylaxis of GVHD consisted of CSA, MP and MMF. Patients with cGVHD received a regimen with combination of MP, MMF and FK506 or CSA. Results Seventeen out of 32 patients who received UCBT were engrafted. while 9 out of 13 patients who received PBSCT were engrafted. Nine cases of the 30 engrafted patients developed cGVHD (morbidity 30%). Among the 17 patients who received UCBT, 3 developed cGVHD (18%). Among the 13 patients who received PBSCT, 6 developed cGVHD (46%). Six cGVHD continued from aGVHD (6/9). One patient was given CSA plus MMF, and 8 were given three-drug regimen with MP, MMF and FK506. The overall response rate was 100%. Two patients died of CMV-IP or septicemia (mortality 20%). Seven (78%) patients survived(event free survival, EFS)longer than 3 years. The side effects included hepatotoxicity, nephrotoxicity, hypertension, articular capsulitis and arrhythmia. The main complication and the major causes of death were infection. Conclusion The incidence of cGVHD is low in children. The incidence of cGVHD after PBSCT is higher than that after UCBT. aGVHD is a highly dangerous factor. Combined therapy of MP plus MMF and FK506 or CSA is safe and effective for the treatment of cGVHD in children." @default.
- W3147291807 created "2021-04-13" @default.
- W3147291807 creator A5042966860 @default.
- W3147291807 date "2005-01-01" @default.
- W3147291807 modified "2023-09-23" @default.
- W3147291807 title "Prophylaxis and treatment of chronic graft versus host disease" @default.
- W3147291807 hasPublicationYear "2005" @default.
- W3147291807 type Work @default.
- W3147291807 sameAs 3147291807 @default.
- W3147291807 citedByCount "0" @default.
- W3147291807 crossrefType "journal-article" @default.
- W3147291807 hasAuthorship W3147291807A5042966860 @default.
- W3147291807 hasConcept C126322002 @default.
- W3147291807 hasConcept C141071460 @default.
- W3147291807 hasConcept C2776694085 @default.
- W3147291807 hasConcept C2776755627 @default.
- W3147291807 hasConcept C2777408962 @default.
- W3147291807 hasConcept C2779968505 @default.
- W3147291807 hasConcept C2779972918 @default.
- W3147291807 hasConcept C2780611847 @default.
- W3147291807 hasConcept C2781413609 @default.
- W3147291807 hasConcept C2909675724 @default.
- W3147291807 hasConcept C2911091166 @default.
- W3147291807 hasConcept C71924100 @default.
- W3147291807 hasConcept C90924648 @default.
- W3147291807 hasConceptScore W3147291807C126322002 @default.
- W3147291807 hasConceptScore W3147291807C141071460 @default.
- W3147291807 hasConceptScore W3147291807C2776694085 @default.
- W3147291807 hasConceptScore W3147291807C2776755627 @default.
- W3147291807 hasConceptScore W3147291807C2777408962 @default.
- W3147291807 hasConceptScore W3147291807C2779968505 @default.
- W3147291807 hasConceptScore W3147291807C2779972918 @default.
- W3147291807 hasConceptScore W3147291807C2780611847 @default.
- W3147291807 hasConceptScore W3147291807C2781413609 @default.
- W3147291807 hasConceptScore W3147291807C2909675724 @default.
- W3147291807 hasConceptScore W3147291807C2911091166 @default.
- W3147291807 hasConceptScore W3147291807C71924100 @default.
- W3147291807 hasConceptScore W3147291807C90924648 @default.
- W3147291807 hasLocation W31472918071 @default.
- W3147291807 hasOpenAccess W3147291807 @default.
- W3147291807 hasPrimaryLocation W31472918071 @default.
- W3147291807 hasRelatedWork W1972954994 @default.
- W3147291807 hasRelatedWork W2051785605 @default.
- W3147291807 hasRelatedWork W2055468114 @default.
- W3147291807 hasRelatedWork W2072277949 @default.
- W3147291807 hasRelatedWork W2130948352 @default.
- W3147291807 hasRelatedWork W2348696897 @default.
- W3147291807 hasRelatedWork W2356535674 @default.
- W3147291807 hasRelatedWork W2375707721 @default.
- W3147291807 hasRelatedWork W2418478478 @default.
- W3147291807 hasRelatedWork W2550449227 @default.
- W3147291807 hasRelatedWork W2553096785 @default.
- W3147291807 hasRelatedWork W2565641320 @default.
- W3147291807 hasRelatedWork W2566594863 @default.
- W3147291807 hasRelatedWork W2579140131 @default.
- W3147291807 hasRelatedWork W2979912649 @default.
- W3147291807 hasRelatedWork W3001511621 @default.
- W3147291807 hasRelatedWork W3022007010 @default.
- W3147291807 hasRelatedWork W3039888522 @default.
- W3147291807 hasRelatedWork W3126014774 @default.
- W3147291807 hasRelatedWork W3138767028 @default.
- W3147291807 isParatext "false" @default.
- W3147291807 isRetracted "false" @default.
- W3147291807 magId "3147291807" @default.
- W3147291807 workType "article" @default.